The Triological Society is investing in the future of otolaryngology-head and neck surgery with the debut of its TRIO Leadership Academy.
Innovations in Otolaryngology: Two Paths to Progress
Otolaryngology is experiencing significant developments from both scientific research and patient-driven recognition of conditions. Two key innovations are gene therapy for hearing loss and the identification and treatment of retrograde cricopharyngeal dysfunction, which illustrate different origins of medical progress.
How to Have Effective Presurgical Discussions
Effective presurgical discussions are essential for helping patients make informed decisions and feel comfortable with their treatment options.
Advocacy: Finding Our Voice
Dr. Lindsay reflects on her first experience participating in Advocacy Day, organized by the AAO-HNS, highlighting the importance of physician advocacy beyond clinical care.
A Royal Family Heritage: The Habsburg Jaw
What is the “Habsburg jaw,” and what does historical and genetic literature suggest about its inheritance and contemporary corrective options?
Inflammatory Markers Stratify Surgical Outcomes in Pediatric Airway Reconstruction
Do serological inflammatory markers and clinical risk factors help predict outcomes in pediatric aerodigestive patients undergoing airway reconstruction?
Efficacy of Local Bupivacaine Injection for Post-Operative Pain in Endoscopic Sinus Surgery
Does general anesthesia in combination with local bupivacaine injection at the SPG and anterior ethmoid nerve reduce post-operative pain after
ESS?
Healthcare Resource Utilization and Cost After TCRF Treatment of Nasal Airway Obstruction: A Real-World Longitudinal Claims Analysis
Does TCRF treatment for NVC-related NAO reduce healthcare utilization and overall costs compared with medical management?
Optimizing Pediatric Sleep-Disordered Breathing Screening: Key Predictive Questions Identified from CHAT and PATS Databases
Can a small set of screening questions accurately predict or rule out severe pediatric OSA?
What Is the Current Management of Osteoradionecrosis of the Temporal Bone Following Head and Neck Cancer Radiotherapy?
Temporal bone ORN is a rare but serious complication of head and neck cancer treatment. Medical management, including topical antimicrobials, debridement, PENTO protocol, HBO therapy, and pain relief, can be effective for localized cases. Surgical intervention is recommended for diffuse disease, severe pain, uncontrolled infections, cholesteatomas, and patients over 60. More research and randomized control trials are needed to determine the best treatment approaches.
- 1
- 2
- 3
- …
- 346
- Next Page »